| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $228.6M | — | +16.5% |
| Cost of Revenue | $34.7M | — | +16.1% |
| Gross Profit | $193.9M | — | +16.6% |
| R&D Expense | $49.3M | — | +23.1% |
| SG&A Expense | $40.4M | — | -14.4% |
| Operating Income | -$8.1M | — | +22.6% |
| Pre-tax Income | -$6.6M | — | -359.9% |
| Income Tax | -$1.8M | — | -147.3% |
| Net Income | -$4.8M | — | -268.9% |
| EPS (Basic) | -$0.02 | — | — |
| EPS (Diluted) | -$0.02 | — | — |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $548.2M | -3.8% | -7.8% |
| Short-term Investments | $231.1M | +9.2% | -42.4% |
| Accounts Receivable | $127.3M | -15.6% | +13.4% |
| Current Assets | $1.01B | -8.2% | -15.8% |
| Total Assets | $1.61B | +0.2% | +4.2% |
| Current Liabilities | $520.1M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $62.4M | — | +7.6% |
| Capital Expenditures | $3.9M | — | +201.0% |
| Investing Cash Flow | -$82.3M | — | -277.9% |
| Financing Cash Flow | -$55.5M | — | +57.4% |
| Free Cash Flow | $58.5M | — | +3.2% |
| +25.8% |
| Total Liabilities | $586.2M | +2.8% | +22.3% |
| Stockholders' Equity | $1.02B | -1.3% | -4.0% |